We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
French drugmaker Aventis yesterday recommended that shareholders reject an unsolicited $60 billion acquisition bid from smaller French rival Sanofi-Synthelabo, arguing the offer undervalues the firm.
With the reimbursement rates for Medicare-covered drugs having changed at the beginning of the year in response to the Medicare prescription drug benefit law, drugmakers
Rather than focusing solely on product and brand management, drugmakers are turning to patient-oriented efforts such as Rx compliance and disease management programs to increase revenue, according to a report from Cutting Edge Information.
U.S. drug manufacturers intent on controlling the reimportation of drugs from Canada have won the support of the Canadian International Pharmacy Association (CIPA), which recently told a number of state and local agencies in the U.S. its 27-member mail-order pharmacy association will not engage in formal commercial agreements with them.